Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2025-12-24 @ 7:57 PM
NCT ID: NCT03025204
Eligibility Criteria: Inclusion Criteria: * Diagnosis of generalized aggressive periodontitis (verified by the presence of periodontal pockets and radiological loss in patients under the 35 years old at the time of diagnosis); or a diagnosis of generalized chronic periodontitis (in patients over 35 years old); * Presence of infra-osseous defect in radiographic examination with minimum dimensions of 4mm deep and 2mm of horizontal component, associated to periodontal pocket of at least 6mm of PD; * Presence of at least 15 teeth of the oral cavity; * To present less than 20% of plaque index and bleeding on probing after 6 weeks of initial therapy; * Formal consent for participation in research, after explaining the risks and benefits for individual not involved in it. (Resolution No. 196 of October 1996 and the Dental Code of Professional Ethics (C.F.O.) 179/93). Exclusion Criteria: Presence of periapical or pulpal alteration; * Presence of systemic alteration or use of medications (6 months prior to the study) that may influence the response to periodontal treatment; * Pregnant and lactating women; * Smoking; * Periodontal treatment including subgingival instrumentation in the 6 weeks prior to the study; * Teeth with bifurcation involvement; * Teeth with marked mobility; * Oral pathology, chronic disease or history of allergy to any component of the study; * Previous periodontal surgery in the region of interest.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT03025204
Study Brief:
Protocol Section: NCT03025204